<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<GBSeq>

    <GBSeq_locus>OF382126</GBSeq_locus>
    <GBSeq_length>188</GBSeq_length>
    <GBSeq_strandedness>double</GBSeq_strandedness>
    <GBSeq_moltype>DNA</GBSeq_moltype>
    <GBSeq_topology>linear</GBSeq_topology>
    <GBSeq_division>PAT</GBSeq_division>
    <GBSeq_update-date>19-JAN-2023</GBSeq_update-date>
    <GBSeq_create-date>19-JAN-2023</GBSeq_create-date>
    <GBSeq_definition>KR 1020220008280-A/11: COMPOSITIONS USEFUL FOR TREATMENT OF POMPE DISEASE</GBSeq_definition>
    <GBSeq_primary-accession>OF382126</GBSeq_primary-accession>
    <GBSeq_accession-version>OF382126.1</GBSeq_accession-version>
    <GBSeq_other-seqids>
      <GBSeqid>dbj|OF382126.1|</GBSeqid>
      <GBSeqid>pat|KR|1020220008280|11</GBSeqid>
      <GBSeqid>gi|2430031627</GBSeqid>
    </GBSeq_other-seqids>
    <GBSeq_keywords>
      <GBKeyword>KR 1020220008280-A/11</GBKeyword>
    </GBSeq_keywords>
    <GBSeq_source>adeno-associated virus 2</GBSeq_source>
    <GBSeq_organism>adeno-associated virus 2</GBSeq_organism>
    <GBSeq_taxonomy>Viruses; Monodnaviria; Shotokuvirae; Cossaviricota; Quintoviricetes; Piccovirales; Parvoviridae; Parvovirinae; Dependoparvovirus; Dependoparvovirus primate1</GBSeq_taxonomy>
    <GBSeq_references>
      <GBReference>
        <GBReference_reference>1</GBReference_reference>
        <GBReference_position>1..188</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Wilson,J.M.</GBAuthor>
          <GBAuthor>Hordeaux,J.</GBAuthor>
          <GBAuthor>Do,H.V.</GBAuthor>
          <GBAuthor>Gotschall,R.</GBAuthor>
          <GBAuthor>Tuske,S.</GBAuthor>
        </GBReference_authors>
        <GBReference_title>COMPOSITIONS USEFUL FOR TREATMENT OF POMPE DISEASE</GBReference_title>
        <GBReference_journal>KR1020220008280-A 11 20-JAN-2022 The Trustees of the University of Pennsylvania|AMICUS THERAPEUTICS, INC</GBReference_journal>
      </GBReference>
    </GBSeq_references>
    <GBSeq_comment>KN KR 1020217038223-A/11~AN KR 1020217038223~AD 2021-11-23~PN KR 1020220008280~PD 2022-01-20~AT COMPOSITIONS USEFUL FOR TREATMENT OF POMPE DISEASE~AI Wilson, James M.|Hordeaux, Juliette|Do, Hung V|Gotschall,~AI Russell|Tuske, Steven~AA The Trustees of the University of Pennsylvania|AMICUS~AA THERAPEUTICS, INC.~PR US 62/913,401=2019-10-10|US 62/840,911=2019-04-30~OS adeno-associated virus 2~TY DNA~FH Key Location/Qualifiers.</GBSeq_comment>
    <GBSeq_feature-table>
      <GBFeature>
        <GBFeature_key>source</GBFeature_key>
        <GBFeature_location>1..188</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>1</GBInterval_from>
            <GBInterval_to>188</GBInterval_to>
            <GBInterval_accession>OF382126.1</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>organism</GBQualifier_name>
            <GBQualifier_value>adeno-associated virus 2</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>mol_type</GBQualifier_name>
            <GBQualifier_value>unassigned DNA</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>db_xref</GBQualifier_name>
            <GBQualifier_value>taxon:10804</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
    </GBSeq_feature-table>
    <GBSeq_sequence>tcttcctagagcatggctacgtagataagtagcatggcgggttaatcattaactacaaggaacccctagtgatggagttggccactccctctctgcgcgctcgctcgctcactgaggccgggcgaccaaaggtcgcccgacgcccgggctttgcccgggcggcctcagtgagcgagcgagcgcgcagc</GBSeq_sequence>
  </GBSeq>
